---
title: "SSY Group Files Disclosure with HKEX on Repurchase of 1.49 Million Shares at HKD 3.03–3.05 Each"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/271900854.md"
datetime: "2026-01-08T08:35:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/271900854.md)
  - [en](https://longbridge.com/en/news/271900854.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/271900854.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/271900854.md) | [繁體中文](https://longbridge.com/zh-HK/news/271900854.md)


# SSY Group Files Disclosure with HKEX on Repurchase of 1.49 Million Shares at HKD 3.03–3.05 Each

SSY Group Ltd. has filed a next day disclosure return with the Hong Kong Stock Exchange, reporting the repurchase of 1,486,000 shares at an aggregate price of HKD 4,521,660. The repurchased shares will be held as treasury shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SSY Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260108-11984724), on January 08, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [SSY GROUP (02005.HK)](https://longbridge.com/en/quote/02005.HK.md)

## Related News & Research

- [SSY Group Profit Halves as Revenue and Margins Slide in Challenging 2025](https://longbridge.com/en/news/280725971.md)
- [SSY Group Wins China Approval for Upadacitinib Bulk Drug](https://longbridge.com/en/news/281103720.md)
- [Currys Reduces Share Count with Latest Buy-Back Transaction](https://longbridge.com/en/news/281319173.md)
- [BH Macro steps up buybacks and support measures after muted 2025 returns](https://longbridge.com/en/news/281166932.md)
- [PATEO CONNECT Plans On-Market Buyback of Up to 10% of H Shares](https://longbridge.com/en/news/280628535.md)